NK cells do not secrete IL-1 and IL-6, which may cause CRS, because their cytokine profiles differ from those of T cells, making CAR-NK therapy less likely to cause fatal side effects than CAR-T therapy. The gene discussed is IL1B; the disease is congenital rubella syndrome.